1. Introduction
===============

Selenium- and tellurium-containing compounds have drawn the attention of the scientific community due to their biological properties \[[@B1-molecules-16-08098],[@B2-molecules-16-08098],[@B3-molecules-16-08098],[@B4-molecules-16-08098]\]. Notwithstanding the intense activity in the field of selenium and tellurium chemistry over the last three decades, organometallic reagents are commonly employed on the preparation of organo-selenium and -tellurium compounds. Moreover, hypervalent organoselenium(IV) compounds (organoselenanes) and organotellurium(IV) compounds (organotelluranes) have been investigated as cysteine protease \[[@B5-molecules-16-08098],[@B6-molecules-16-08098],[@B7-molecules-16-08098],[@B8-molecules-16-08098]\], protein tyrosine phosphatase \[[@B9-molecules-16-08098]\] and poliovirus 3C proteinase inhibitors \[[@B10-molecules-16-08098]\]. Considering the biological activities of organoselenanes and telluranes, we have described chemoenzymatic methodologies to synthesize selenium compounds without employing organolithium or organomagnesium reagents \[[@B11-molecules-16-08098],[@B12-molecules-16-08098]\]. Herein, we report the preparation of enantiopure organochalcogenane precursors, (*R*)- and (*S*)-*tert*-butyl 2-(1-hydroxyethyl)phenylcarbamate, employing enzymatic kinetic resolution (EKR) catalyzed by lipases. The chiral building blocks \[(*R*)-**I** and (*S*)-**I**\] could be applied as advanced synthetic intermediates of organotelluranes and organoselenanes **III**, containing an asymmetric center ([Scheme 1](#molecules-16-08098-f001){ref-type="fig"}). It is possible to transform (*R*)-**I** and (*S*)-**I** into their respective arene diazonium salts, followed by a reaction with a nucleophilic selenium/tellurium specie to give selenides/tellurides **II**, direct precursors of selenanes and telullaranes \[[@B12-molecules-16-08098]\].

![Synthetic route to bioactive chalcogenanes \[[@B5-molecules-16-08098],[@B6-molecules-16-08098],[@B9-molecules-16-08098],[@B12-molecules-16-08098]\].](molecules-16-08098-g001){#molecules-16-08098-f001}

2. Results and Discussion
=========================

As outlined in [Scheme 2](#molecules-16-08098-f002){ref-type="fig"}, chiral building blocks (*R*)-**3** and (*S*)-**3** could be synthesized from commercially available 1-(2-aminophenyl)ethanone (**1**). Initially, the amine protection leads to the *N*-Boc-protected arylketone **2**, which by reduction of the ketone group affords (*R*,*S*)-**3**. Then, the latter could be submitted to an enzymatic kinetic resolution (EKR) and, at the end of the process, both enantiomers could be easily separated.

2.1. Synthesis of the (R,S)-tert-butyl 2-(1-Hydroxyethyl)phenylcarbamate *(**3**)*
----------------------------------------------------------------------------------

Several methods were evaluated to synthesize *tert*-butyl (2-acetylphenyl)carbamate (**2**) ([Table 1](#molecules-16-08098-t001){ref-type="table"}). The protection of amine group was carried out by reacting 1-(2-aminophenyl)ethanone (**1**) with *tert*-butyl dicarbonate \[(Boc)~2~O\]. For example, by using dichloromethane (CH~2~Cl~2~) as solvent and DMAP as additive, after 24 h at room temperature, compound **2** was obtained in 60% yield (Entry 1). It is worth mentioning that the intermediate **1a** was observed, then easily transformed to the compound **2** \[[@B13-molecules-16-08098]\]. A second method, employing THF as solvent and under reflux was evaluated. However, a slight yield improvement (compound **2**, 67%) was observed with a shorter reaction time, 12 h (Entry 2). Other reaction conditions were evaluated; however, the yields were lower than 40% (Entries 3--5). Next, we decided to apply the second method (Entry 2) to prepare the compound **2** in a preparative scale (5 mmol).

![Synthetic route to enantiopure *tert*-butyl 2-(1-hydroxyethyl)phenylcarbamates.](molecules-16-08098-g002){#molecules-16-08098-f002}

molecules-16-08098-t001_Table 1

###### 

Synthesis of *tert*-butyl (2-acetylphenyl)carbamate (**2**).

![](molecules-16-08098-i001.jpg)

  Entry   Additive (amount)     Solvent      t (°C)    Time (h)   Yield 2 (%)   Ref.
  ------- --------------------- ------------ --------- ---------- ------------- ---------------------------------------------------------
  1       DMAP (1 equiv.)       CH~2~Cl~2~   r.t.      24         60            \[[@B13-molecules-16-08098]\]
  2       DMAP (1 equiv.)       THF          reflux    12         67            \[[@B13-molecules-16-08098],[@B14-molecules-16-08098]\]
  3       I~2~ (2 equiv.)       \--          r.t.      12         37 ^a^        \[[@B15-molecules-16-08098]\]
  4       NaHCO~3~ (2 equiv.)   Dioxane      r.t.      12         traces ^a^    \[[@B16-molecules-16-08098]\]
  5       NaOH (2 equiv.)       Dioxane      0--r.t.   12         traces ^a^    \[[@B17-molecules-16-08098]\]

Reaction conditions: Compound **1** (0.5 mmol), Boc)~2~O (1 mmol), solvent (5 mL), additive; ^a^ Determined by GC analysis; r.t. = room temperature.

The reduction of *tert*-butyl (2-acetylphenyl)carbamate (**2**) with NaBH~4~ gave (*R,S*)-*tert*-butyl 2-(1-hydroxyethyl)phenylcarbamate (**3**) in 84% yield ([Scheme 3](#molecules-16-08098-f003){ref-type="fig"}). The acylated derivative (*R,S*)-**4** was efficiently synthesized from (*R,S*)-**3** and acetic anhydride (92% yield, [Scheme 3](#molecules-16-08098-f003){ref-type="fig"}).

![Synthesis of racemic compounds **3** and **4**.](molecules-16-08098-g003){#molecules-16-08098-f003}

2.2. Enzymatic Kinetic Resolution of the (R,S)-tert-butyl 2-(1-Hydroxyethyl)*phenylcarbamate (**3**)*
-----------------------------------------------------------------------------------------------------

### 2.2.1. Screening of Lipases for Kinetic Resolution of (*R,S*)-**3**

A screening set with 12 different lipases was carried out, looking for a enzyme able to mediate the transesterification of (*R,S*)-**3** with high enantioselectivity and conversion in a short reaction time ([Table 2](#molecules-16-08098-t002){ref-type="table"}).

molecules-16-08098-t002_Table 2

###### 

Screening of lipases for kinetic resolution of (*R,S*)-**3c**.

![](molecules-16-08098-i002.jpg)

  Entry   Lipase                                                                Time (h)   c ^a^(%)   *ee*^b^ (%) (*S*)-3 (*R*)-4   *E* ^c^   
  ------- --------------------------------------------------------------------- ---------- ---------- ----------------------------- --------- -------
  1       *Candida Antarctica* (Novozym^®^ 435; immobilized on acrylic resin)   12         47         88                            \>99      \>200
  2       24                                                                    50         \>99       \>99                          \>200     
  3       48                                                                    51         \>99       95                            \>200     
  4       *Pseudomonas cepacia* (immobilized on ceramics)                       12         33         49                            \>99      \>200
  5       24                                                                    44         77         \>99                          \>200     
  6       48                                                                    49         95         \>99                          \>200     
  7       *Pseudomonas cepacia* (immobilized on diatomite)                      12         16         19                            \>99      \>200
  8       24                                                                    26         34         \>99                          \>200     
  9       48                                                                    36         56         \>99                          \>200     
  10      *Candida rugosa*                                                      12         14         13                            81        10
  11      24                                                                    17         17         81                            11        
  12      48                                                                    21         21         80                            11        
  13      *Candida cylindracea*                                                 12         12         11                            84        12
  14      24                                                                    15         14         81                            10        
  15      48                                                                    18         17         80                            10        
  16      *Candida*sp. (Novozymes^®^ CALB L)                                    24         \<5 ^d^    nd                            nd        nd
  17      *Thermomyces lanuginosus*                                             24         \<5 ^d^    nd                            nd        nd
  18      *Rhizomucor miehei*                                                   24         \<5 ^d^    nd                            nd        nd
  19      Porcine pancreas lipase                                               24         \<5 ^d^    nd                            nd        nd
  20      *Aspergillus niger*                                                   24         \<5 ^d^    nd                            nd        nd
  21      *Pseudomonas fluorescens*                                             24         \<5 ^d^    nd                            nd        nd
  22      *Penicillium camemberti*                                              24         \<5 ^d^    nd                            nd        nd
  23      *Mucor javanicus*                                                     24         \<5 ^d^    nd                            nd        nd
  24      *Pseudomonas cepacia*                                                 24         \<5 ^d^    nd                            nd        nd

Reaction conditions: Compound (*R*,*S*)-**3** (0.25 mmol), lipase (20 mg), vinyl acetate (1 mmol), hexane (1 mL), 35 °C, 160 rpm; ^a^ conversion: c = 100 × (*ee~s~*/*ee~s~* + *ee~p~*); ^b^ enantiomeric excess: determined by HPLC analysis; ^c^ Enantiomeric ratio: *E* = ln{\[*ee**~P~*** (1 − *ee**~S~***)\]/(*ee**~P~*** + *ee**~S~***)}/ln{\[*ee**~P~*** (1 + *ee**~S~***)\]/(*ee**~P~*** + *ee**~S~***)}; ^d^ determined by GC analysis; nd: not determined due to low conversion.

Among the different type of lipases that were used as biocatalysts in the transesterification reaction, CAL-B presented high values of both conversion and enantioselectivity (Entries 1--3). After 12 h CAL-B-catalyzed reaction showed 47% conversion, high enantiomeric excess (*ee*) for (*S*)-**3** (88%) and (*R*)-**4** (\>99%), and an enantiomeric ratio (*E*) higher than 200 (Entry 1). After 24 h, the conversion increased to 50% and both (*S*)-**3** and (*R*)-**4** were obtained with *ee* \> 99% (Entry 2). After 48 h, the conversion was higher than 50% and consequently the *ee* of (*R*)-**4** dropped to 95%. Based on these results, 24 h was selected as the most appropriate time to interrupt the kinetic resolution process.

*Pseudomonas cepacia* lipases also presented interesting results, but slightly inferior to those of CAL-B. For *P. cepacia* immobilized on ceramics, we observed high *ee* for (*R*)-**4** (\>99%) and *E* \> 200 after 12 h (Entry 4). But, even after 48 h the conversion did not reach 50% and consequently the maximum *ee* for (*S*)-**3** was 95% (Entry 6). For *P. cepacia* immobilized on diatomite, the conversion was lower than 40% and 56% *ee* for (*S*)-**3** (Entry 9).

Lipases from *Candida rugosa*, *Candida cylindracea*, *Candida sp.*, *Thermomyces lanuginosus*, *Rhizomucor miehei*, porcine pancreas, *Aspergillus niger*, *Pseudomonas fluorescens*, *Penicillium camemberti*, *Mucor javanicus*, *Pseudomonas cepacia* showed discouraging results (Entries 10--24), including cases in which the conversion was lower than 5% (Entries 16--24). Then, the CAL-B was selected as the appropriate lipase to be applied to the next studies.

### 2.2.2. Influence of Solvent in the Kinetic Resolution of (*R,S*)-**3**

The solvent influence on EKR of (*R,S*)-**3** was also investigated ([Table 3](#molecules-16-08098-t003){ref-type="table"}). The results demonstrated that the reaction in hexane presented high conversion (50%) and excellent enantioselectivity. For those reactions in toluene (Entries 3 and 4) and methyl *tert*-butyl ether (Entries 5 and 6) slightly inferior results were observed, in comparison with hexane. On the other hand, THF, CHCl~3~, *i*-PrOH and *i*-BuOH (Entries 7--10) showed a dramatic influence on the conversion, which resulted in low values, \<30%.

### 2.2.3. Influence of Temperature in the Kinetic Resolution of (*R,S*)-**3**.

The temperature influence on EKR of (*R,S*)-**3** ([Table 4](#molecules-16-08098-t004){ref-type="table"}) was also studied. Different reaction time was also evaluated (12, 16, 20 and 24 h). In this study, we found that at 25 °C the perfect kinetic resolution of (*R,S*)-**3** was achieved after 24 h (Entry 4). At 35 °C, the optimal values were achieved after 16 h (Entry 6). By increasing the temperature to 40 °C, the desired results were observed in 12 h (Entry 9). The same reaction-time tendency was verified at 50 °C. Therefore, 40 °C was chosen as the best temperature, since a reasonable reaction time with a relative low temperature can be used to obtain an excellent KR of (*R,S*)-**3**.

molecules-16-08098-t003_Table 3

###### 

Influence of solvent in the lipase-catalyzed transesterfication of (*R,S*)-**3**.

![](molecules-16-08098-i003.jpg)

  Entry   Solvent                           Time (h)   c ^a^ (%)   *ee*^b^ (%) (*S*)-3 (*R*)-4   *E* ^c^   
  ------- --------------------------------- ---------- ----------- ----------------------------- --------- -------
  1       Hexane                            12         47          88                            \>99      \>200
  2       24                                50         99          \>99                          \>200     
  3       Toluene                           12         38          61                            \>99      \>200
  4       24                                47         87          \>99                          \>200     
  5       Methyl *tert*-butyl ether (MTE)   12         42          73                            \>99      \>200
  6       24                                49         94          \>99                          \>200     
  7       Tetrahydrofuran (THF)             24         \<30 ^d^    nd                            nd        nd
  8       Cloroform (CHCl~3~)               24         \<30 ^d^    nd                            nd        nd
  9       Isobutylic alcohol (*i*-BuOH)     24         \<30 ^d^    nd                            nd        nd
  10      Diethylic ether (Et~2~O)          24         \<30 ^d^    nd                            nd        nd

Reaction conditions: Compound (*R*,*S*)-**3** (0.25 mmol), CAL-B (20 mg), vinyl acetate (1 mmol), solvent (1 mL), 35 °C, 160 rpm; ^a^ conversion: c = 100 × (*ee~s~*/*ee~s~* + *ee~p~*); ^b^ enantiomeric excess: determined by HPLC analysis; ^c^ Enantiomeric ratio: *E* = ln{\[*ee**~P~*** (1 − *ee**~S~***)\]/(*ee**~P~*** + *ee**~S~***)}/ln{\[*ee**~P~*** (1 + *ee**~S~***)\]/(*ee**~P~*** + *ee**~S~***)}; ^d^ determined by GC analysis; nd: not determined due to low conversion.

molecules-16-08098-t004_Table 4

###### 

Influence of temperature in the lipase-catalyzed transesterfication of (*R,S*)-**3**.

![](molecules-16-08098-i004.jpg)

  Entry   Temperature (°C)   Tempo (h)   c ^a^ (%)   *ee*^b^ (%) (*S*)-3 (*R*)-4   *E* ^c^   
  ------- ------------------ ----------- ----------- ----------------------------- --------- -------
  1       25                 12          45          80                            \>99      \>200
  2       25                 16          46          86                            \>99      \>200
  3       25                 20          49          95                            \>99      \>200
  4       25                 24          50          \>99                          \>99      \>200
  5       35                 12          48          89                            \>99      \>200
  6       35                 16          50          \>99                          \>99      \>200
  7       35                 20          50          \>99                          \>99      \>200
  8       35                 24          50          \>99                          \>99      \>200
  9       40                 12          50          \>99                          \>99      \>200
  10      40                 16          50          \>99                          \>99      \>200
  11      40                 20          51          \>99                          98        \>200
  12      40                 24          52          \>99                          97        \>200
  13      50                 12          50          \>99                          98        \>200
  14      50                 16          50          \>99                          98        \>200
  15      50                 20          52          \>99                          97        \>200
  16      50                 24          53          \>99                          94        \>200

Reaction conditions: Compound (*R*,*S*)-**3** (0,25 mmol), CAL-B (20 mg), vinyl acetate (1 mmol), hexane (1 mL), 160 rpm; ^a^ conversion: c = 100 × (*ee~s~*/*ee~s~* + *ee~p~*); ^b^enantiomeric excess: determined by HPLC analysis; ^c^ Enantiomeric ratio: *E* = ln{\[*ee**~P~*** (1 − *ee**~S~***)\]/(*ee**~P~*** + *ee**~S~***)}/ln{\[*ee**~P~*** (1 + *ee**~S~***)\]/(*ee**~P~*** + *ee**~S~***)}.

### 2.2.4. Study of the Ratio of Enzyme to Substrate for Kinetic Resolution of (*R,S*)-**3**

The ratio enzyme/substrate was also investigated for EKR of (*R*,*S*)-**3** at 40 °C and 12 h ([Table 5](#molecules-16-08098-t005){ref-type="table"}). It was observed that 10 mg of CAL-B was not enough to reach 50% of conversion (Entry 3). By using 20 and 40 mg the desired result was achieved just at the end of the experiments (Entries 6 and 9). However, the reaction with 80 mg of CAL-B showed 50% of conversion after 8 h (Entry 11) and for the reaction with 100 mg only 6 h were needed to obtain the desired results (Entry 13), but we considered the ratio of 100 mg CAL-B to 0.25 mmol substrate impracticable, so 20 mg was chosen as the optimal amount to achieve excellent values of conversion and enantiomeric excess.

molecules-16-08098-t005_Table 5

###### 

Study of ratio CAL-B/substrate for kinetic resolution of (*R,S*)-**3**.

![](molecules-16-08098-i005.jpg)

  Entrada   Massa(mg)   Tempo (h)   c(%) ^a^   *ee* (%) ^b^ 3 4   *E* ^c^   
  --------- ----------- ----------- ---------- ------------------ --------- -------
  1         10          6           30         63                 \>99      \>200
  2         10          8           39         75                 \>99      \>200
  3         10          12          45         90                 \>99      \>200
  4         20          6           40         84                 \>99      \>200
  5         20          8           45         93                 \>99      \>200
  6         20          12          50         \>99               \>99      \>200
  7         40          6           43         86                 \>99      \>200
  8         40          8           48         97                 \>99      \>200
  9         40          12          50         \>99               \>99      \>200
  10        80          6           48         97                 \>99      \>200
  11        80          8           50         \>99               \>99      \>200
  12        80          12          51         \>99               97        \>200
  13        100         6           50         \>99               \>99      \>200
  14        100         8           50         \>99               \>99      \>200
  15        100         12          52         \>99               95        \>200

Reaction conditions: Compound (*R*,*S*)-**3** (0.25 mmol), CAL-B, vinyl acetate (1 mmol), hexane (1 mL), 40 °C, 160 rpm; ^a^ conversion: c = 100 × (*ee~s~*/*ee~s~* + *ee~p~*); ^b^ enantiomeric excess: determined by HPLC analysis; ^c^ Enantiomeric ratio: *E* = ln{\[*ee**~P~*** (1 − *ee**~S~***)\]/(*ee**~P~*** + *ee**~S~***)}/ln{\[*ee**~P~*** (1 + *ee**~S~***)\]/(*ee**~P~*** + *ee**~S~***)}.

In order to obtain the compounds (*S*)-**3** and (*R*)-**3** and to assign the absolute configuration, a reaction on a preparative scale (5 mmol) was carried out. After quenching the reaction, the compounds (*S*)-**3** and (*R*)-**4** were separated by flash gel column chromatography. Then, the ester (*R*)-**4** was submitted to a hydrolysis reaction to give the alcohol (*R*)-**3** ([Scheme 4](#molecules-16-08098-f004){ref-type="fig"}). In this way, both enantiomers of **3** were obtained in high enantiomeric purity (*ee* \> 99%) and yields (\>45%).

![Synthesis of (*R*)- and (*S*)-**3**.](molecules-16-08098-g004){#molecules-16-08098-f004}

The absolute configuration of the compound **3** was indirectly attributed after deprotection of the amino group of (−)-(*S*)-**3** \[[@B18-molecules-16-08098]\]. Then, the optical rotation of the resulting amino-alcohol **5** was measured, and by comparison with literature data \[[@B18-molecules-16-08098]\] its absolute configuration was attributed to (*S*)-**5** ([Table 6](#molecules-16-08098-t006){ref-type="table"}). Consequently, the configuration of the *N*H-Boc protected precursor was also attributed to (*S*)-**3**.

molecules-16-08098-t006_Table 6

###### 

Assignment of the absolute configuration of *tert*-butyl 2-(1-hydroxyethyl)phenylcarbamate (**3**).

![](molecules-16-08098-i006.jpg)

  \#                                         *ee* (%)   \[a\]~D~
  ------------------------------------------ ---------- -----------------------------
  Literature \[[@B18-molecules-16-08098]\]   93         +52, 5 (*c* = 1,0; CHCl~3~)
  This work                                  \>99       +63,1 (*c* = 1,1; CHCl~3~)

3. Experimental Section
=======================

Commercially available materials were used without further purification. Lipase from *Candida antarctica* (fraction B, CAL-B) immobilized, and commercially available as Novozym® 435 was kindly donated by Novozymes Latin America Ltda. All solvents were HPLC or ACS grade. Solvents used for moisture sensitive operations were distilled from drying reagents under a nitrogen atmosphere: THF was distilled from Na/benzophenone.

Analytical thin-layer chromatography (TLC) was performed using aluminum-backed silica plates coated with a 0.25 mm thickness of silica gel 60 F~254~ (Merck), visualized with an ultraviolet light (l = 254 nm), followed by exposure to *p*-anisaldehyde solution or vanillin solution and heating. Standard chromatographic purification methods were followed using 35--70 mm (240--400 mesh) silica gel purchased from Acros Organics^®^.

Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker AC 200 spectrometer at operating frequencies of 200 (^1^H-NMR) and 50 MHz (^13^C-NMR). The ^1^H-NMR chemical shifts are reported in ppm relative to TMS peak. The data are reported as follows: chemical shift (δ), multiplicity (s = singlet, d = doublet, t = triplet, qd = quadruplet, dd = double dublet, td = triple dublet, m = multiplet), and coupling constant (*J*) in Hertz and integrated intensity. The ^13^C-NMR chemical shifts are reported in ppm relative to CDCl~3~ signal.

Reaction products were analyzed by a Shimadzu model GC-17A (FID) gas chromatograph equipped with a J&W Scientific HP5 column (30 m × 0.25 mm I.D.; 0.25 µm). The chromatographic conditions were as follows: Oven temperature initiated at 50 °C and increased at 10 °C/min; run time 20 min; injector temperature 230 °C; detector temperature 250 °C; injector split ratio 1:20; hydrogen carrier gas at a pressure of 100 kPa. The enantiomeric excesses of the products were determined by HPLC analyses performed in a Shimadzu model SPD-10Av instrument with UV-Vis detector (deuterium lamp 190--600 nm) and equipped with a Chiralcel^®^ OD-H column (25 cm × 0.46 cm I.D.; Daicel Chemical Ind.) eluted with *n*-hexane (60%) and 2-propanol (99:1).

High-resolution mass spectra (HRMS) were acquired using a Bruker Daltonics MicroTOF instrument, operating in the electrospray ionization (ESI) mode.

Infrared spectra were recorded from KBr discs or from a thin film between NaCl plates on FTIR spectrometer (Bomem Michelson model 101). Absorption maxima (ν~max~) are reported in wavenumbers (cm^−1^).

Optical rotations were measured on a Perkin Elmer-343 digital polarimeter in a 1 mL cuvette with a 1 dm pathlength. All values are reported in the following format: \[α\]~D~(temperature of measurement) = specific rotation (concentration of the solution reported in units of 10 mg sample per 1 mL solvent used).

3.1. Synthesis of tert-butyl (2-Acetylphenyl)carbamate *(2)* (Adapted from References \[[@B13-molecules-16-08098],[@B14-molecules-16-08098]\])
----------------------------------------------------------------------------------------------------------------------------------------------

To a solution of the 1-(2-aminophenyl)ethanone (**1**, 1.35 g, 10 mmol) in anhydrous THF (100 mL) Boc)~2~O (6.48 g, 30 mmol) was added, followed by DMAP (122 mg, 1 mmol). The solution was stirred under reflux for 12 h then concentrated to dryness and partitioned between 0.5 mol L^−1^ HCl (100 mL) and EtOAc (100 mL). The aqueous layer was extracted with EtOAc (2 × 100 mL) and the combined organic phases were washed with brine (50 mL), dried over MgSO~4~, filtered and concentrated to afford the crude *tert*-butyl (2-acetylphenyl)carbamate (**2**) and the di-Boc derivative products. These compounds were separated by flash silica gel column chromatography eluted with hexane/EtOAc 9:1. (2-Acetylphenyl)carbamate (**2**) and the di-Boc derivative were isolated in 45% and 31% yields, respectively. The di-Boc compound (1.00 g) was dissolved in CH~2~Cl~2~ (100 mL) and Amberlyst 15 resin (1.00 g) was added. The mixture was stirred for 24 h in an orbital shaker. Then, the solvent was removed and the residue filtered through a silica gel column with hexane/EtOAc 9:1. The compound **2** was obtained in 67% yield. ^1^H-NMR (200 MHz, CDCl~3~); d (ppm): 10.95 (s, 1H); 8.46 (d, 1H, *J* = 8.3 Hz); 7.84 (dd, 1H, *J*~A~ = 7.9 Hz; *J*~B~ = 1.32 Hz); 7.50 (td, 1H, *J*~A~ = 8.3 Hz; *J*~B~ = 1.3 Hz); 7.01 (t, 1H, *J* = 7.9 Hz); 2.64 (s, 3H); 1.53 (s, 9H). ^13^C-NMR (50 MHz, CDCl~3~); d (ppm): 202.5; 153.4; 142.0; 135.2; 131.9; 121.6; 121.2; 119.4; 80.7; 28.8. IV (KBr), cm^−1^: 3432; 2947; 1713; 1656; 1562; 1239; 1108; 739. HRMS (ESI), \[M+Na\]^+^: Calculated for C~13~H~17~NO~3~Na: 258.1106. Found: 258, 1104.

3.2. Synthesis of Racemic tert-butyl (2-(1-Hydroxyethyl)phenyl)carbamate \[(*R,S*)-**3**\]
------------------------------------------------------------------------------------------

To a solution of *tert*-butyl (2-acetylphenyl)carbamate (**2**, 1.175 g, 5 mmol) in methanol (50 mL) NaBH~4~ (0.21 g, 5.5 mmol) at 0 °C was added. After adding NaBH~4~, the ice bath was removed and the solution was stirred at room temperature for 2 h then concentrated to dryness. To residue water (30 mL) was added and the pH adjusted to 6.0. In the sequence the mixture was extracted with CH~2~Cl~2~ (3 × 15 mL), dried over MgSO~4~, filtered and concentrated to afford the crude *tert*-butyl (2-(1-hydroxyethyl)phenyl)carbamate (**3**). This was purified by flash silica gel column chromatography eluted with hexane/EtOAc 9:1 to afford **3** in 84% yield. ^1^H-NMR (200 MHz, CDCl~3~);d (ppm): 8.01 (s, 1H); 7.90 (d, 1H, *J* = 8.3 Hz); 7.26 (t, 1H, *J* = 7.5 Hz); 7.14 (d, 1H, *J* = 7.5 Hz); 7,00 (t, 1H, *J* = 7.5 Hz); 4,95 (qd, 1H, *J* = 6.6 Hz); 1.54 (m, 12H). ^13^C-NMR (50 MHz, CDCl~3~); d (ppm): 153.5; 136.7; 132.7; 127.9; 126.4; 122.9; 121.4; 80.0; 69.5; 28.2; 22.1. IR (film), cm^−1^: 3457; 3343; 2979; 1761; 1727; 1524; 1449; 1254. HRMS (ESI), \[M+Na\]^+^: Calculated for C~13~H~19~NO~3~Na: 260.1263. Found: 260.1262.

3.3. Synthesis of Racemic 1-(2-((tert-Butoxycarbonyl)amino)phenyl)ethyl acetate \[(*R,S*)-**4**\]
-------------------------------------------------------------------------------------------------

To a solution of the (2-(1-hydroxyethyl)phenyl)carbamate (**3**, 237 g, 1 mmol) in pyridine (2 mL) was added Ac~2~O (0.10 g, 1 mmol). The solution was stirred at room temperature overnight then diluted in EtOAc (20 mL) and washed with CuSO~4~ (5 mL portions) to the complete removal of the pyridine. The organic phase was dried over MgSO~4~, filtered and concentrated to afford the crude 1-(2-((*tert*-butoxycarbonyl)amino)phenyl)ethyl acetate (**4**). The crude material was purified by flash silica gel column chromatography eluted with hexane/EtOAc 9:1 to afford **4** in 92% yield. ^1^H-NMR (200 MHz, CDCl~3~); d (ppm): 7.78 (d, 2H, *J* = 8.1 Hz); 7.66 (s, 1H); 7.32 (m, 2H); 7.12 (td, 1H, *J*~A~ = 7.5 Hz; *J*~B~ = 0.8 Hz); 5.98 (qd, 1H, *J* = 6.4 Hz); 2.0 (s, 3H); 1.61 (d, 3H, *J* = 6.4 Hz); 1.5 (s, 9H). ^13^C-NMR (50 MHz, CDCl~3~); d (ppm): 170.2; 152.8; 135.1; 130.7; 128.1; 126.3; 123.6; 122.9; 79.3; 68.1; 27.6; 20.3; 20.0. IR (film), cm^−1^: 3432; 3338; 2980; 1731; 1591; 1519; 1453; 1241; 1160. HRMS (*ESI*), \[M+Na\]^+^: Calculated for C~15~H~21~NO~4~Na: 302.1368. Found 302.1364.

3.4. Enzymatic Kinetic Resolution of the (R,S)-tert-butyl 2-(1-Hydroxyethyl)phenylcarbamate \[(*R,S*)-**3**\]
-------------------------------------------------------------------------------------------------------------

To solution of racemic *tert*-butyl (2-(1-hydroxyethyl)phenyl)carbamate (**3**, 1.185 g; 5 mmol) in hexane (20 mL), CAL-B (Novozym^®^ 435; 400 mg) and vinyl acetate (1.72 g; 20 mmol) were added. The mixture was stirred in an orbital shaker at 40 °C for 12 h (160 rpm). Following that, the enzyme was filtered off and washed with dichloromethane (3 × 20 mL). The solvent was removed under reduced pressure and the residue was purified by flash silica gel column chromatography eluted with hexane/EtOAc 9:1 to afford (*S*)-**3** (*ee* \> 99%) in 47% yield and (*R*)-**4** (*ee* \> 99%) in 45% yield.

3.5. HPLC Analysis of (S)- and (R)-tert-butyl (2-(1-Hydroxyethyl)phenyl)carbamate (**3**)
-----------------------------------------------------------------------------------------

HPLC conditions: Chiralcel^®^ OD-H column, *n*-hexane/*i*-PrOH (99:1), 1.0 mL min^−1^, 254 nm UV detector. (*S*)-**3**: isolated yield = 45%; retention time: 23.7 min; *ee* \> 99%; \[α\]~D~^22^ = −7.7 (*c*= 1.63; CHCl~3~). (*R*)-**3**: Isolated yield = 45%; retention time: 29.2 min; *ee* \> 99%; \[α\]~D~^22^ = 7.0 (*c*= 1.22; CHCl~3~).

3.6. General Procedure to Remove Boc-Protecting Group (Adapted from Reference \[[@B19-molecules-16-08098]\])
------------------------------------------------------------------------------------------------------------

To a mixture of AcOEt:HCl 3 mol L^−1^ 1:1 (5 mL), *N*-Boc protected compound (1 mmol) was added. The mixture was stirred at room temperature for 1 h. After that, the solvent was removed under vacuum. The residue was dissolved in CH~2~Cl~2~ (10 mL) and washed with saturated NaHCO~3~ solution (3 × 3 mL). Then, the organic layer was dried over MgSO~4~, filtered and concentrated to dryness under vacuum. The product was obtained in quantitative yield without further purification.

4. Conclusions
==============

In summary, we have described an efficient methodology to obtain (*R*)- and (*S*)-*tert*-butyl 2-(1-hydroxyethyl)phenylcarbamates in enantiopure form (*ee* \> 99%), using a kinetic resolution process mediated by lipase as a biocatalyst. Both enantiomers can be employed in the preparation of organochalcogenanes for further application in biological studies.
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